Check out what's new at GVK BIO
Wednesday, June 25, 2008
, , , ,
, ,
Welcome to the inaugural issue of the GVK BIO newsletter.

GVK BIO has witnessed remarkable growth in the short period since its inception in 2001. We are fortunate to be associated with organizations such as yours and together we have moved forward.

The newsletter introduces new appointees as we continue to develop expertise and services. GVK BIO has partnered with top Pharma and Life-sciences companies. You will read more about it in the newsletter. GVK BIO offers innovative solutions and products – see how the Biomarker Database helps your drug discovery process. GVK BIO with a prestigious client, hosted a landmark Symposium and brought several international stalwarts to the same dais – Symposium in Organic Synthesis.

Lastly, being the first issue, we have a small write-up on GVK BIO’s service offerings.

We welcome and look forward to your feedback. Please write to us if you any feedback for us on the newsletter or on any other aspect of our work.

Best regards,
rajiv varma
GVK BIO enters into Drug Discovery Pact with Wyeth Pharmaceuticals
GVK BIO entered into a research agreement with Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), to discover drug candidates focused on pre-defined discovery targets. GVK BIO will utilize in-house capabilities in Discovery Chemistry, Informatics, Biology and ADME to advance this program. GVK BIO will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance these compounds towards clinical studies. Under the agreement, GVK BIO will receive an initial payment and will be eligible for success-based milestone payments.
readmoreRead more
Rajiv Varma is new President of Inogent Laboratories – a GVK BIO associate
Inogent Laboratories (Inogent Labs), a Hyderabad-based custom synthesis and API manufacturing company, announced the appointment of Rajiv Varma as the new President of the company. In his new role as President, Varma will be responsible for Inogent operations and help the company grow as a leading contract research and custom manufacturing services provider.
readmoreRead more
The GVK BIO Biomarker Database is coming shortly!
GVK Biosciences will launch a manually curated database of clinical biomarkers that it has been developing in collaboration with an undisclosed large pharmaceutical firm for two years. It was awarded the ‘Best CRO in Drug Discovery Services in India’ in 2005 by Proximare and was identified as one of the ‘Top 20 companies to watch for in 2006’ by Business Today.
readmoreRead more
Dow AgroSciences, GVK Biosciences Announce Collaboration on Fungicide and
Insecticide Discovery Research

Dow AgroSciences LLC and GVK BIO have entered into a discovery research agreement to combine both companies’ expertise to generate novel molecules for synthesis and testing as fungicides and insecticides.

The two companies will use the depth of expertise in medicinal chemistry and cheminformatics at GVK in combination with Dow AgroSciences agrochemical capabilities in this new collaboration. GVK BIO will work with Dow AgroSciences to transform science into solutions.

readmoreRead more
Sequoia Capital invests Rs.100 crores in GVK BIO - To fund expansions and offer
integrated services
GVK BIO, a leading Pharma & Biotech research and development outsourcing company, announced that Sequoia Capital a leading global private investment firm has invested Rs.100 crores in the company.
It was awarded the ‘Best CRO in Drug Discovery Services in India’ in 2005 by Proximare and was identified as one of the ‘Top 20 companies to watch for in 2006’ by Business Today.
readmoreRead more
GVK BIO-Wyeth Hyderabad Research Center
The GVK BIO-Wyeth Hyderabad Chemistry Center was inaugurated by Dr. Robert Ruffolo, President R&D, Wyeth Pharma. Mr. David Hopper, the Consul General, United States Consulate, Chennai
readmoreRead more
Symposium in Organic Synthesis
GVK Biosciences and Wyeth Pharma organized an international symposium on the 05th of October 2007 on “New Dimensions in Organic Synthesis” at the Hyderabad International Convention Center (HICC). World renowned leaders in Chemistry presented on various topics including crystal engineering, chemical tools for the study of complex biological systems, approaches to novel chemical reactions, synergy between natural products & drug discovery and total synthesis efforts.
readmoreRead more
GVK BIO – Asia’s leading Contract Research Organization
GVK Biosciences Pvt. Ltd. is one of India’s premier CROs with a leadership position in Drug Discovery services. It has shown consistent growth by strengthening its leadership in core areas (Medicinal Chemistry, Informatics) and expanding into new service offerings (spanning Drug Discovery to Development and Custom Synthesis). It was awarded the ‘Best CRO in Drug Discovery Services in India’ in 2005 by Proximare and was identified as one of the ‘Top 20 companies to watch for in 2006’ by Business Today.
readmoreRead more
GVK BIO will be at the following conferences this year. Please contact us if you are interested to meet us at any of the conferences.
Conference Date Location
Protein Kinase and Structure Based Design June 25-27, 2008 World Trade Center,
Boston, USA
ACS Fall Meeting August 17-21, 2008 Philadelphia, USA
Biotech Outsourcing Strategies September 06, 2008 Cambridge, UK
ChemOutsourcing Conference & Exhibition September 08-09, 2008 Philadelphia, USA
PABOARD September 13-14, 2008 London, UK
CPhI September 30-October 02, 2008 Frankfurt, Germany
Please do not reply to this message, it sent from an unattended mailbox. To change your preferences or unsubscribe please use the links below. To ensure delivery and proper display of our emails, please add the from email to your address book. Please enable the viewing of remote images in our emails.

GVK Biosciences Private Limited
#210, 6-3-1192, Kundanbagh, Begumpet
Hyderabad – 500016, India

Copyright © 2008 GVK BIO All rights reserved
To unsubscribe click here